Literature DB >> 29785016

Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.

Nadjla Alsadoun1, Gaëtan MacGrogan2, Caroline Truntzer3, Magali Lacroix-Triki4, Isabelle Bedgedjian5, Marie-Hélène Koeb6, Elsy El Alam7, Dan Medioni8, Michel Parent9, Pascal Wuithier10, Isabelle Robert11, Romain Boidot3, Laurent Arnould3.   

Abstract

Solid papillary carcinoma with reverse polarity is a rare breast cancer of favorable prognosis that can be difficult to diagnose. We report here nine additional cases of this tumor, and we describe its morphologic, immunohistochemical and molecular profile in comparison to other types of papillary and micropapillary lesions of the breast that are intraductal papilloma with usual ductal hyperplasia, encapsulated papillary carcinoma, solid papillary carcinoma and invasive micropapillary carcinoma. We studied nine cases of this special papillary tumor and six of each other types mentioned above. We found that solid papillary carcinoma with reverse polarity harbor specific morphologic features as cuboid or tall cells with abundant eosinophilic cytoplasms located at the basal pole giving the impression of reverse nuclear polarity. Nuclei were sometimes grooved. Immunohistochemistry demonstrated the lack of myoepithelial cells, as in encapsulated papillary carcinoma and solid papillary carcinoma, questioning their invasive nature. Seven of nine solid papillary carcinoma with reverse polarity showed a low Ki67 proliferative index (Ki67 <5%). They showed expression of CK5/6 as in intraductal papilloma with usual ductal hyperplasia. They showed expression of calretinin and a low or lack of hormonal receptor (HR) expression that were not observed in other breast tumors studied. By whole-exome analysis, seven of nine solid papillary carcinomas with reverse polarity (78%) harbored a hotspot mutation in IDH2 (R172) that was totally absent in other groups. Six of nine tumors (67%) also harbored PRUNE2 mutation, including the two IDH2 wild-type cases. We also demonstrated for the first time in this breast tumor, immunostaining with a specific antibody IDH1/2 mutant R132/R172 (7/9) that can highlight IDH2 mutation. Moreover, transcriptomic analysis showed that proteoglycan pathway was significantly enriched. Our findings support the fact that solid papillary carcinoma with reverse polarity is a singular breast neoplasm that can be distinguished from other papillary breast tumors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29785016     DOI: 10.1038/s41379-018-0047-1

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   8.209


  13 in total

1.  Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.

Authors:  Julie Massé; Caroline Truntzer; Romain Boidot; Emmanuel Khalifa; Gaëlle Pérot; Valérie Velasco; Laétitia Mayeur; Claire Billerey-Larmonier; Larry Blanchard; Hélène Charitansky; Isabelle Soubeyran; Richard Iggo; Laurent Arnould; Gaëtan MacGrogan
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

2.  Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.

Authors:  Yufan Wei; Liming Ding; Xin Song; Xia Tian; Ningning Min; Qingyu Guan; Xiru Li; Mei Liu
Journal:  Gland Surg       Date:  2021-11

3.  Codon 172 in the IDH2 gene is a mutational hotspot in tall cell carcinoma with reversed polarity of the breast.

Authors:  Eiichi Sasaki; Katsuhiro Masago
Journal:  Gland Surg       Date:  2022-06

Review 4.  Problematic breast tumors reassessed in light of novel molecular data.

Authors:  Fresia Pareja; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

Review 5.  Papillary neoplasms of the breast-reviewing the spectrum.

Authors:  Timothy Kwang Yong Tay; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-01-18       Impact factor: 7.842

6.  Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review.

Authors:  Xiaohui Zhang; Huanwen Wu; Zhe Wang; Yidong Zhou; Feng Mao; Yan Lin; Songjie Shen; Zhiyong Liang; Qiang Sun
Journal:  Gland Surg       Date:  2021-02

7.  Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.

Authors:  Anthony Bergeron; Gaëtan MacGrogan; Aurélie Bertaut; Sylvain Ladoire; Patrick Arveux; Isabelle Desmoulins; Hervé Bonnefoi; Catherine Loustalot; Sophie Auriol; Françoise Beltjens; Emilie Degrolard-Courcet; Céline Charon-Barra; Corentin Richard; Romain Boidot; Laurent Arnould
Journal:  Mod Pathol       Date:  2021-03-22       Impact factor: 8.209

8.  Histological Aspects and Quantitative Assessment of Ki67 as Prognostic Factors in Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study.

Authors:  Irina Niță; Cornelia Nițipir; Ștefania Andreea Toma; Alexandra Maria Limbău; Edvina Pîrvu; Ioana Anca Bădărău; Ioana Suciu; George Suciu; Loredana Sabina Cornelia Manolescu
Journal:  Medicina (Kaunas)       Date:  2020-11-09       Impact factor: 2.430

Review 9.  Breast carcinomas of low malignant potential.

Authors:  Stuart J Schnitt; Falko Fend; Thomas Decker
Journal:  Virchows Arch       Date:  2021-07-22       Impact factor: 4.064

Review 10.  Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.

Authors:  Ashley Cimino-Mathews
Journal:  Mod Pathol       Date:  2020-10-27       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.